CAPTAIN T CELL
Captain T Cell is a start-up project that develops T cell-based immunotherapies for cancer patients. The company identifies novel high-efficiency TCRs for the development of T cell immunotherapies. It focuses on CMC- and preclinical development for their lead candidates.
CAPTAIN T CELL
Industry:
Health Care Therapeutics Wellness
Address:
Berlin, Berlin, Germany
Country:
Germany
Status:
Active
Current Employees Featured
More informations about "Captain T Cell"
Captain T Cell - Crunchbase Company Profile & Funding
Captain T Cell may be growing as evidenced by the recent announcement of a manufacturing alliance with Charles River for gene-modified therapies. This partnership indicates an expansion of operations and could potentially lead to …See details»
Charles River and Captain T Cell Announce Plasmid DNA and Viral …
WILMINGTON, Mass., June 17, 2024--Charles River Laboratories International, Inc. (NYSE: CRL) and Captain T Cell, a spinoff from the renowned Max Delbrück Center Berlin, Germany, today …See details»
NEWS - captaintcell.com
May 22, 2024 Captain T Cell Secures Seed Financing Round Totaling €8.5 Million Schoenefeld/Berlin, Germany, May 22, 2024 — Captain T Cell GmbH, a biotechnology …See details»
Charles River and Captain T Cell Form Alliance for Gene Therapy ...
The agreement will provide Captain T Cell with access to Charles River’s extensive CDMO (Contract Development and Manufacturing Organization) capabilities and advisory services, …See details»
Charles River and Captain T Cell Announce Plasmid DNA and Viral …
Jun 17, 2024 As part of Charles River’s Cell and Gene Therapy (CGT) Accelerator Program (CAP), Captain T Cell will have access to established plasmid and viral vector contract …See details»
Charles River and Captain T Cell Announce Plasmid DNA and Viral …
Jun 17, 2024 As part of Charles River’s Cell and Gene Therapy (CGT) Accelerator Program (CAP), Captain T Cell will have access to established plasmid and viral vector contract …See details»
Charles River and Captain T Cell Join Forces to Advance
Jun 17, 2024 The partnership entails a plasmid DNA and retrovirus vector production program agreement, an endeavor that holds immense promise for the future of personalized …See details»
Charles River Joins Forces with Captain T Cell for TCR-T …
Jun 18, 2024 By employing advanced technologies, Captain T Cell generates tumor-specific T cell receptors (TCR) with enhanced persistence and the ability to withstand hostile tumor microenvironments. Leveraging Charles River’s …See details»
Captain T Cell - Drug pipelines, Patents, Clinical trials - Synapse
Captain T Cell is based in Schoenefeld/Berlin, Germany, and backed by leading European investors i&i Biotech Fund I SCSp, Brandenburg Kapital GmbH, and HIL-INVENT Ges.m.b.H. …See details»
Charles River and Captain T Cell Announce Plasmid DNA and Viral …
Jun 17, 2024 Cell and Gene Therapy CDMO Solutions To bring its gene-modified cell therapy to clinic, Captain T Cell will leverage Charles River’s established plasmid and viral vector …See details»
Charles River (CRL) Advances in T-Cell Therapy With New Alliance
Jun 18, 2024 Charles River (CRL) and Captain T Cell announced an agreement on plasmid DNA and retrovirus vector production program for the treatment of patients having solid tumor.See details»
Charles River (CRL) Advances in T-Cell Therapy With New Alliance
Charles River Laboratories International, Inc.CRL and Captain T Cell, a spinoff from Max Delbrück Center in Germany, entered into an agreement on plasmid DNA and retrovirus vector …See details»
Charles River, Captain T Cell Sign Plasmid DNA & Viral Vector ...
Jun 17, 2024 As part of Charles River’s Cell and Gene Therapy (CGT) Accelerator Program (CAP), Captain T Cell will have access to established plasmid and viral vector contract …See details»
Charles River and Captain T Cell sign vector production agreement
Jun 18, 2024 The collaboration is part of Charles River's Cell and Gene Therapy (CGT) Accelerator Program, which provides Captain T Cell with access to contract development and …See details»
Captain T Cell Secures $8.5M Seed Funding to Advance …
Captain T Cell, a groundbreaking biotech company based in Germany, announced the successful completion of their latest funding round, raising an impressive $8,500,000. The company …See details»
Captain T Cell - Contacts, Employees, Board Members
Captain T Cell is a start-up project that develops T cell-based immunotherapies for cancer patients. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. …See details»
Captain T Cell Secures Seed Financing Round Totaling € 8.5 ... - i&i …
May 22, 2024 Schoenefeld/Berlin, Germany, May 22, 2024. Captain T Cell GmbH, a biotechnology company developing next-generation T cells against solid tumors, today …See details»
Captain T Cell secures seed financing round - bionity.com
May 28, 2024 Captain T Cell is a spin-off from the Max Delbrück Center for Molecular Medicine in the Helmholtz Association. The startup builds on years of research and innovations …See details»
A pilot raced through the airport to surprise an old friend: the …
9 hours ago He reached out to the jet’s captain. And dashed to the gate. David Whitson, a United Airlines pilot, received a rare diagnosis in August 2016 and had only one hope for survival.See details»